Rapamycin stands as the most robust and reproducible pharmacological intervention for extending lifespan across the evolutionary spectrum, from yeast to mammals. While animal data is overwhelming, leading longevity researchers are currently locked in a complex debate regarding the safety, dosing, and potential functional trade-offs of using this drug in healthy humans [1]. This expert-led exploration…

Is rapamycin overhyped in the longevity community, or is it a scientific breakthrough that can finally slow human aging? While some claim it is the most promising anti-aging drug today, critics argue that the rapamycin longevity hype has outpaced the actual rapamycin anti-aging evidence in humans [1] [2]. Preclinical data shows rapamycin is the most…

The pursuit of longevity often leads researchers and self-experimenters to rapamycin, yet many fail to realize that sirolimus bioavailability is not a fixed number—it is a moving target dictated by chemical engineering. While the active molecule remains the same, the vehicle delivering it determines whether you achieve life-extending mTOR inhibition or simply expensive, unabsorbed waste.…